Overview
Perrault syndrome is a rare autosomal recessive disorder characterized by sensorineural hearing loss (SNHL) in both males and females, combined with ovarian dysgenesis (streak gonads) in affected females. The condition was first described by Maurice Perrault in 1951. Males with Perrault syndrome typically present with hearing loss alone, which can make diagnosis more challenging in the absence of affected female siblings. The hearing loss is bilateral and sensorineural, ranging from mild to profound, and may be present from birth or develop in early childhood. Affected females experience primary amenorrhea and infertility due to gonadal dysgenesis, with a 46,XX karyotype distinguishing the condition from Turner syndrome. Several genes have been identified as causative, including HSD17B4, HARS2, LARS2, CLPP, C10orf2 (TWNK), and ERAL1, all of which encode proteins involved in mitochondrial function or steroidogenesis. Some patients may develop additional neurological features, including progressive cerebellar ataxia, intellectual disability, and peripheral neuropathy, which has led to the distinction between Perrault syndrome type I (hearing loss and ovarian dysgenesis without neurological involvement) and type II (with neurological features). The neurological manifestations can be progressive and significantly impact quality of life. There is currently no cure or disease-modifying treatment for Perrault syndrome. Management is supportive and multidisciplinary, involving hearing aids or cochlear implants for hearing loss, hormone replacement therapy (estrogen and progesterone) for females with ovarian dysgenesis to induce secondary sexual characteristics and protect bone health, and neurological rehabilitation for those with cerebellar or peripheral nervous system involvement. Genetic counseling is recommended for affected families. Fertility is not achievable in affected females due to the absence of functional ovarian tissue, though options such as egg donation may be discussed.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Perrault syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Perrault syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Perrault syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Perrault syndrome.
Community
No community posts yet. Be the first to share your experience with Perrault syndrome.
Start the conversation →Latest news about Perrault syndrome
No recent news articles for Perrault syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Perrault syndrome
What is Perrault syndrome?
Perrault syndrome is a rare autosomal recessive disorder characterized by sensorineural hearing loss (SNHL) in both males and females, combined with ovarian dysgenesis (streak gonads) in affected females. The condition was first described by Maurice Perrault in 1951. Males with Perrault syndrome typically present with hearing loss alone, which can make diagnosis more challenging in the absence of affected female siblings. The hearing loss is bilateral and sensorineural, ranging from mild to profound, and may be present from birth or develop in early childhood. Affected females experience prima
How is Perrault syndrome inherited?
Perrault syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.